Acute Myocradial Infarction, Primary Percutanious Coronary Intervention (PCI) in an Anticoagulated Patient for Mitalic Mitral Valve Replacement (MVR)
Last updated: 03 Jan 2025
10.21608/ejhm.2021.161771
Acute myocardial infarction, Major bleeding, Percutaneouscoronary intervention, Warfarin
Aeham
Rabadi
Cardiology Department, Queen Alia Heart Institute (QAHI), Royal Medical Services (RMS), Jordan
ayhamrabai84@gmail.com
Mohammad
Alsmadi
Gastroentrology Department, King Husain Medical City, Royal Medical Services (RMS), Jordan
Rayya
Almashagbeh
Cardiology Department, Queen Alia Heart Institute (QAHI), Royal Medical Services (RMS), Jordan
Yazan
Banihamad
Cardiology Department, Queen Alia Heart Institute (QAHI), Royal Medical Services (RMS), Jordan
Tareq
AL-Qudah
Cardiology Department, Queen Alia Heart Institute (QAHI), Royal Medical Services (RMS), Jordan
83
1
23025
2021-04-01
2021-04-06
2021-04-01
1,162
1,164
1687-2002
2090-7125
https://ejhm.journals.ekb.eg/article_161771.html
https://ejhm.journals.ekb.eg/service?article_code=161771
55
Original Article
606
Journal
The Egyptian Journal of Hospital Medicine
https://ejhm.journals.ekb.eg/
Acute Myocradial Infarction, Primary Percutanious Coronary Intervention (PCI) in an Anticoagulated Patient for Mitalic Mitral Valve Replacement (MVR)
Details
Type
Article
Created At
22 Jan 2023